(1 year, 8 months ago)
Lords ChamberI thank the noble Lord for raising this issue and for the points that he has made, but we believe there is already a robust and comprehensive ecosystem of laws and norms to protect civilians displaced by conflict. However, he is right that the UK should use our position of leadership to highlight this issue politically and raise it on the global stage—and we do so. We regularly engage in UN discussions, including at UNGA and the UN Security Council, and underline the responsibility of all states engaged in armed conflict to respect international humanitarian law and international refugee law and act in accordance with our obligations under them. The UK has been one of the most consistent and loudest voices on the subject for some time.
My Lords, I am grateful to the Minister for—I think—being clear that His Majesty’s Government still support the refugee convention, as I think he suggested that they are promoting it on the world stage. Will he commit to promoting it with his Home Office colleagues as well?
My Lords, the UN High Commissioner for Refugees is a key partner for the UK. It provides protection and humanitarian assistance to refugees and other displaced persons. We have provided the UNHCR with more than £70 million in 2022-23, including £25 million for the Ukraine response.
(3 years ago)
Lords ChamberMy Lords, it is a bitter irony indeed that tomorrow’s ministerial meeting of the WTO has had to be cancelled indefinitely because of a variant that could have been prevented had we all collaborated sooner on, for example, the TRIPS waiver. Given that the overwhelming majority of the R&D money spent on vaccines came from public and philanthropic funds, is it not time that the European Union stopped blocking the TRIPS waiver and that Her Majesty’s Government sided with the United States, India, South Africa and much of the global south, so that we do not just donate but collaborate over patents and know-how?
My Lords, the UK is engaging intensively and constructively in the TRIPS waiver debate. We continue to be open to all ideas that have a positive impact on vaccine production and distribution. A balanced and effective intellectual property regime has proved invaluable in this crisis, as in others, in supporting innovation and collaboration. In the meantime, we know we need to continue to push ahead with pragmatic action now, including voluntary licensing and technology transfer agreements.